US Attorney General Jeff Sessions on Thursday called a barrage of criticism from President Donald Trump “hurtful” — but vowed to remain in his post, Guardian reports.
The president has launched a series of attacks against his top law enforcement official in recent days, furious at Sessions for recusing himself from a probe into alleged Russian ties to Trump’s election campaign.
Sessions has remained largely silent in response but, in an interview with Fox News during a visit to El Salvador, he admitted to being stung by the president’s comments.
“It is kind of hurtful, but the president of the United States is a strong leader,” said Sessions, a former senator from Alabama who was one of the first senior politicians to endorse Trump.
Sessions said that Trump’s overwhelming desire was for “all of us to do our jobs. That’s what I intend to do.”
The attorney general stepped away in March from overseeing the FBI-led Russia probe after it emerged he had not disclosed during his Senate confirmation hearing that he met twice with the Russian ambassador to Washington.
In an interview with The New York Times last week, Trump said he would never have appointed Sessions had he known he would recuse himself from the Russia probe.
He later called him out on Twitter, saying he had been “VERY weak” for failing to open a criminal investigation into his defeated election rival Hillary Clinton.
The attacks, widely seen as designed to force Sessions into resigning, have upset leading figures in Trump’s Republican Party, who have sprung to the attorney general’s defense.
“If Jeff Sessions is fired, there will be holy hell to pay,” Republican Senator Lindsey Graham warned Thursday.
US Attorney General Jeff Sessions on Thursday called a barrage of criticism from President Donald Trump “hurtful” — but vowed to remain in ...
Sundar Pichai, the Chief Executive Officer (CEO) of Google Inc., who is currently in Nigeria was recorded dancing to Small Doctor’s Penalty.
The Google For Nigeria event has been holding all week at the Landmark Event Center, Victoria Island, Lagos where the CEO himself made a memorable appearance.
He had a brief interview session with media veteran Adesuwa Onyenokwe on stage. When asked how the experience of being to Nigeria for the first time has been, Pichai said,
“The potential of the country is huge and the energy of the people here is awesome.”
He also learned to say “O da bo.”
This was evidently an exciting experience for him, we do hope to see more of his dancing skills. Watch the video below and share your comments below.
http://ift.tt/2tJqHNi
Sundar Pichai, the Chief Executive Officer (CEO) of Google Inc., who is currently in Nigeria was recorded dancing to Small Doctor’s Penalty....
President Donald Trump in a series of tweets has announced that from now on, transgender people would not be allowed to serve in the U.S. military in any capacity. The president said he came to this decision after consulting with his Military Generals and Military Experts.
The Pentagon in 2016 lifted a ban on transgender men and women serving in the military, the then-Defense Secretary Ashton Carter said “Our mission is to defend this country, and we don’t want barriers unrelated to a person’s qualification to serve to prevent us from recruiting or retaining the soldier, sailor, airman or Marine who can best accomplish the mission, we have to have access to 100% of America’s population for our all-volunteer force to be able to recruit from among them the most highly qualified — and to retain them”.
According to Huffington Post, while campaigning in 2016, Trump claimed he was better for lesbian, gay, bisexual and transgender Americans than Democratic rival Hillary Clinton, evaded being drafted into the military, five times, once arguing he couldn’t serve because of bone spurs in his heels.
President Donald Trump in a series of tweets has announced that from now on, transgender people would not be allowed to serve in the U.S. mi...
Researchers say monthly vaginal ring and daily oral tablet, both containing anti-HIV drugs, are safe and acceptable in adolescent girls.
The results of the study were presented on Wednesday at the 9th IAS Conference on HIV Science in Paris, France.
The study reveals that the use of dapivirine vaginal ring by adolescent girls, most or all of the time, reduces the risk of HIV infection in women by no less than 56 per cent.
Dr Sharon Hillier, the Principal Investigator, NIH-funded Microbicide Trials Network (MTN), said the researchers were encouraged by the result of the dapivirine ring in 15 to 17 year-old girls.
“The study has demonstrated that the ring is safe in US teens, and now we need data on the safety and acceptability of the ring in African adolescent girls.
“The REACH study, scheduled to launch later this year, will generate this data,’’ she said.
Hillier stated that an earlier NIAID-funded study called ASPIRE, which enrolled women ages from 18 to 45, tested a ring that continuously releases the experimental anti-HIV drug dapivirine in the vagina over one month.
“The results, reported in 2016, showed 27 per cent protection overall but no protection in women ages 18 to 21, likely due to low adherence.
“A subsequent exploratory analysis of ASPIRE study data found that, using the ring most or all of the time reduces the risk of HIV infection in women by at least 56 per cent.’’
Hillier said that a phase 2a clinical trial, called MTN-023/IPM 030, was conducted in the United States to examine the safety and acceptability of the dapivirine ring among sexually active girls from 15 to 17 years old.
“ Adolescent girls and young women, ages 15 to 24, are at particularly high risk for HIV infection. They accounted for 20 per cent of new HIV infections among adults globally in 2015.
“Ninety-six girls enrolled at six U.S. sites were assigned at random to receive either the dapivirine ring or a placebo ring in a 3-to-1 ratio.
“Neither the participants nor the investigators knew who had received which ring until the end of the trial. Participants were asked to insert a new ring each month for 6 months.
“Researchers monitored participants’ health and gauged adherence by measuring the amount of dapivirine in blood samples and used rings.’’
Hillier further stated that the study revealed that the dapivirine ring was safe and acceptable to participants.
‘’Adherence to the ring was high: drug levels in 87 per cent of blood samples and 95 per cent of used rings met pre-specified adherence criteria.
“Overall, participants said they liked the ring at 93 per cent of study visits but were concerned about keeping the ring clean and fear of it being felt by primary sexual partner during sex.’’
Hillier said that the MTN investigators would in the study tagged `REACH’ assess how study participants used the monthly ring and daily PrEP and their preferences for either or both approaches.
Hillier is a Professor and Director of reproductive infectious disease research, Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Pittsburgh School of Medicine.
Similarly, Dr Anthony Fauci has said that adherence to the ring was high, adding that adherence to the tablet was moderate and diminished substantially when study visits became less frequent.
Fauci, a Director, National Institute of Allergy and Infectious Diseases (NIAID), said that it was the first clinical trial of the oral tablet as pre-exposure prophylaxis (PrEP), specifically for adolescents girls.
He said that the findings paved way for larger trials of the vaginal ring and oral PrEP in this vulnerable age group.
“Adolescents and young people represent a growing share of people living with HIV worldwide.
“Science has demonstrated that the HIV prevention needs of adolescents may be different from those of adults, which is why these new study findings are so important,’’ he said. (Vanguard)
Researchers say monthly vaginal ring and daily oral tablet, both containing anti-HIV drugs, are safe and acceptable in adolescent girls. T...